Zentalis Pharmaceuticals, Inc.·4

Jan 9, 8:36 PM ET

Vultaggio Vincent 4

4 · Zentalis Pharmaceuticals, Inc. · Filed Jan 9, 2026

Insider Transaction Report

Form 4
Period: 2026-01-08
Transactions
  • Award

    Stock Option (Right to Buy)

    2026-01-08+100,000100,000 total
    Exercise: $2.84Exp: 2036-01-07Stock Option (100,000 underlying)
Footnotes (1)
  • [F1]The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Documents

3 files